X

Trial Profile

A Phase II Study of Intravenous (IV) Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the Urothelium.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 03 Sep 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vinflunine (Primary)
Indications Bladder cancer; Urogenital cancer
Focus Therapeutic Use
Sponsors Bristol-Myers Squibb

Most Recent Events

10 May 2011 This trial is recruiting in Spain, but has completed in Italy and Sweden.
10 May 2011 New source identified and integrated (European Clinical Trials Database; 2005-001463-64)
26 Jun 2009 Results from this trial was used to support a positive opinion of vinflunine for the treatment of bladder cancer issued by the Committee for Medicinal Products for Human Use, according to a Pierre Fabre media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com